Finished Dosage Formulation (FDF)

According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market. Read more


Manufacturer and supplier of controlled substance APIs, Noramco, and manufacturer and supplier of functional excipient platforms, SPI Pharma, have signed an agreement to develop and license a set of ‘value-added’ formulation packages Read more


CPhI Worldwide has released the findings from its debate on the global growth in finished dosage forms, ahead of the launch of a new co-located event at CPhI Worldwide on October 4th and 6th. Read more


CPhI Worldwide, organised by UBM EMEA, has introduced a co-located event dedicated to Finished Dosage Formulation (FDF) Read more